JP2023524102A5 - - Google Patents
Info
- Publication number
- JP2023524102A5 JP2023524102A5 JP2022566628A JP2022566628A JP2023524102A5 JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5 JP 2022566628 A JP2022566628 A JP 2022566628A JP 2022566628 A JP2022566628 A JP 2022566628A JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- abcb5
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018440P | 2020-04-30 | 2020-04-30 | |
| US63/018,440 | 2020-04-30 | ||
| PCT/US2021/030342 WO2021222861A1 (en) | 2020-04-30 | 2021-04-30 | Antibodies specific to abcb5 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524102A JP2023524102A (ja) | 2023-06-08 |
| JP2023524102A5 true JP2023524102A5 (https=) | 2024-05-13 |
Family
ID=78373989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566628A Pending JP2023524102A (ja) | 2020-04-30 | 2021-04-30 | Ａｂｃｂ５に特異的な抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230203153A1 (https=) |
| EP (1) | EP4142793A4 (https=) |
| JP (1) | JP2023524102A (https=) |
| KR (1) | KR20230034944A (https=) |
| CN (1) | CN116096753A (https=) |
| AU (1) | AU2021262864A1 (https=) |
| CA (1) | CA3181591A1 (https=) |
| WO (1) | WO2021222861A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019210109A1 (en) | 2018-04-25 | 2019-10-31 | Children's Medical Center Corporation | Abcb5 ligands and substrates |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| AU2020361622A1 (en) * | 2019-10-10 | 2022-04-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic viruses that express multi-specific immune cell engagers |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| WO2025004683A1 (ja) * | 2023-06-30 | 2025-01-02 | 国立大学法人大阪大学 | がん検査方法及びがん治療剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1290028B1 (en) * | 2000-06-05 | 2009-12-23 | The Brigham And Women's Hospital, Inc. | A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| DK2155248T3 (en) * | 2007-04-12 | 2015-09-14 | Brigham & Womens Hospital | Targeting abcb5 for cancer therapy |
| WO2010065711A1 (en) * | 2008-12-04 | 2010-06-10 | Adimab, Inc. | An abcb5 epitope and antibodies thereto for the treatment of cancer |
| WO2016179576A1 (en) * | 2015-05-07 | 2016-11-10 | Bioxcel Corporation | Novel immunomodulatory therapeutic strategies targeting tumors in cancer |
| CN114245741A (zh) * | 2019-03-28 | 2022-03-25 | 儿童医学中心公司 | 高功能性的制造的abcb5+间充质干细胞 |
-
2021
- 2021-04-30 AU AU2021262864A patent/AU2021262864A1/en active Pending
- 2021-04-30 CA CA3181591A patent/CA3181591A1/en active Pending
- 2021-04-30 CN CN202180046044.6A patent/CN116096753A/zh active Pending
- 2021-04-30 KR KR1020227042053A patent/KR20230034944A/ko active Pending
- 2021-04-30 WO PCT/US2021/030342 patent/WO2021222861A1/en not_active Ceased
- 2021-04-30 US US17/922,286 patent/US20230203153A1/en active Pending
- 2021-04-30 JP JP2022566628A patent/JP2023524102A/ja active Pending
- 2021-04-30 EP EP21796792.6A patent/EP4142793A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524102A5 (https=) | ||
| US12122830B1 (en) | Anti-ROR1 antibody and use thereof | |
| JP7150880B2 (ja) | 抗－ｂ７－ｈ３抗体およびその用途 | |
| JP2019116474A5 (https=) | ||
| US9758586B2 (en) | Chimeric rabbit/human ROR1 antibodies | |
| JP2022541435A5 (https=) | ||
| JP2013506428A5 (https=) | ||
| US20230391882A1 (en) | Combination treatment | |
| JP2019535670A5 (https=) | ||
| AU2016233495A2 (en) | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof | |
| JP2019518068A (ja) | グリコシル化免疫チェックポイントタンパク質に特異的に結合する抗体を選択する方法 | |
| JP2018522888A5 (https=) | ||
| JP2020533004A5 (https=) | ||
| JP2022523710A5 (https=) | ||
| JP2022527151A5 (https=) | ||
| KR20220111308A (ko) | 인간화 cldn18.2 항체 | |
| CN114634569A (zh) | 高亲和力b7-h6抗体和抗体片段 | |
| JP2020534012A5 (https=) | ||
| RU2021111382A (ru) | Мультивалентные и мультиспецифические гибридные белки, связывающиеся с dr5 | |
| JP2019512207A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| JP2022553922A5 (https=) | ||
| JP2023537002A5 (https=) | ||
| JP2024506550A5 (https=) | ||
| JP2024515560A5 (https=) |